Front. Oncol.
Frontiers in Oncology
Front. Oncol.
2234-943X
Frontiers Media S.A.
10.3389/fonc.2020.01573
Oncology
Erratum
Erratum: Neoadjuvant Four-Drug Combination Therapy for NSCLC With EGFR Mutation Avoiding Total Pneumonectomy
Frontiers Production Office
*
Frontiers Media SA, Lausanne, Switzerland
Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland
*Correspondence: Frontiers Production Office production.office@frontiersin.org
This article was submitted to Thoracic Oncology, a section of the journal Frontiers in Oncology
29
07
2020
2020
10
1573
20
07
2020
21
07
2020
Copyright © 2020 Frontiers Production Office.
2020
Frontiers Production Office
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
An Erratum on Neoadjuvant Four-Drug Combination Therapy for NSCLC With EGFR Mutation Avoiding Total Pneumonectomy by Li, J., Xu, K., Cai, W., Zhang, Y., Zeng, X., Cui, F., et al. (2020). Front. Oncol. 10:1145. doi: 10.3389/fonc.2020.01145
neoadjuvant
EGFR mutation
targeted (selective) treatment
chemothearpy
surgery
Due to an editorial error, the wrong version of the manuscript was typeset and published. The publisher apologizes for this mistake. The original article has been updated.